PHARMACY

Generics makers set sights on complex generics, biosimilars
Generics makers Lupin and Dr. Reddy's in recent presentations signaled a focus on complex delivery systems and biosimilars as a path to growth.
Acquisition brings Benzer to Empire State
The Tampa, Fla.-based company recently finalized the purchase of Amenia, N.Y. drug store Drug World Pharmacy, marking its New York entry.

FDA approves expanded Rituxan indication

With this approval — which saw the drug given Priority Review, Breakthrough Therapy Designation and Orphan Drug Designation by the FDA — Rituxan becomes the first biologic therapy for the disease.
Abbott launches new generation of Afinion test system

The Afinion 2 streamlines and simplifies the delivery of accurate measurements of hemoglobin A1c, or HbA1c, and albumin to creatinine ratio results at the point of care, the company said.
Amerigen launches generic Targretin capsules

The drug is indicated to treat skin problems that arise from cutaneous T-cell lymphoma in patients who have not responded well to other treatments.
Express Scripts, MedAvail pilot Rx kiosks

The companies are rolling out MedAvail’s MedCenter self-service pharmacy kiosks in Phoenix and Tucson, offering securely dispensed chronic and acute prescriptions, as well as OTC medications 24/7.
Fred’s closes specialty pharmacy sale

The Memphis-based company unloaded the business unit, EntrustRx, to a CVS Health subsidiary for a $40 million aggregate consideration, plus the value of its inventory.
Amgen’s Herceptin biosimilar rejected by FDA

The Food and Drug Administration sent Amgen a complete response letter for its Biologics License application for potential Herceptin biosimilar ABP 90.
Lupin gets FDA OK for generic Mycolog-II cream

The generic Mycolog-II cream market size was roughly $62.2 million for the 12 months ended April 2018.
FDA approves Fulphila, the first U.S. Neulasta biosimilar

Fulphila is the first U.S. biosimilar of the drug from Amgen and is indicated to reduce the duration of febrile neutropenia in patients treated with chemotherapy in certain types of cancer.